Compare J.B.Chemicals with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AUROBINDO PHARMA - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AUROBINDO PHARMA J.B.CHEMICALS/
AUROBINDO PHARMA
 
P/E (TTM) x 31.1 11.3 276.5% View Chart
P/BV x 6.6 1.4 482.9% View Chart
Dividend Yield % 1.1 0.8 136.5%  

Financials

 J.B.CHEMICALS   AUROBINDO PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-21
AUROBINDO PHARMA
Mar-21
J.B.CHEMICALS/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs1,3181,023 128.8%   
Low Rs443333 132.9%   
Sales per share (Unadj.) Rs264.3422.8 62.5%  
Earnings per share (Unadj.) Rs58.092.0 63.1%  
Cash flow per share (Unadj.) Rs66.9110.0 60.8%  
Dividends per share (Unadj.) Rs16.504.00 412.5%  
Avg Dividend yield %1.90.6 317.8%  
Book value per share (Unadj.) Rs234.2374.3 62.6%  
Shares outstanding (eoy) m77.28585.94 13.2%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.31.6 207.7%   
Avg P/E ratio x15.27.4 205.7%  
P/CF ratio (eoy) x13.26.2 213.4%  
Price / Book Value ratio x3.81.8 207.5%  
Dividend payout %28.44.3 653.7%   
Avg Mkt Cap Rs m68,043397,398 17.1%   
No. of employees `000NANA-   
Total wages/salary Rs m3,40635,350 9.6%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m20,425247,746 8.2%  
Other income Rs m1,1663,809 30.6%   
Total revenues Rs m21,591251,555 8.6%   
Gross profit Rs m5,56281,480 6.8%  
Depreciation Rs m68710,554 6.5%   
Interest Rs m72745 9.7%   
Profit before tax Rs m5,96973,990 8.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,48420,098 7.4%   
Profit after tax Rs m4,48553,892 8.3%  
Gross profit margin %27.232.9 82.8%  
Effective tax rate %24.927.2 91.5%   
Net profit margin %22.021.8 100.9%  
BALANCE SHEET DATA
Current assets Rs m18,939198,235 9.6%   
Current liabilities Rs m6,866106,652 6.4%   
Net working cap to sales %59.137.0 159.9%  
Current ratio x2.81.9 148.4%  
Inventory Days Days12219 637.3%  
Debtors Days Days69552 1,346.9%  
Net fixed assets Rs m6,786135,778 5.0%   
Share capital Rs m155586 26.4%   
"Free" reserves Rs m17,943218,713 8.2%   
Net worth Rs m18,097219,299 8.3%   
Long term debt Rs m01,684 0.0%   
Total assets Rs m25,725334,013 7.7%  
Interest coverage x83.4100.3 83.2%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.7 107.0%   
Return on assets %17.716.4 108.3%  
Return on equity %24.824.6 100.9%  
Return on capital %33.433.8 98.7%  
Exports to sales %053.8 0.0%   
Imports to sales %016.4 0.0%   
Exports (fob) Rs mNA133,248 0.0%   
Imports (cif) Rs mNA40,615 0.0%   
Fx inflow Rs m9,082133,248 6.8%   
Fx outflow Rs m1,79244,946 4.0%   
Net fx Rs m7,29088,302 8.3%   
CASH FLOW
From Operations Rs m3,14833,289 9.5%  
From Investments Rs m-2,3075,987 -38.5%  
From Financial Activity Rs m-874-13,648 6.4%  
Net Cashflow Rs m-3325,831 -0.1%  

Share Holding

Indian Promoters % 0.0 48.8 -  
Foreign collaborators % 54.0 3.1 1,759.0%  
Indian inst/Mut Fund % 26.1 38.3 68.2%  
FIIs % 9.2 20.8 44.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 46.0 48.2 95.5%  
Shareholders   61,314 338,639 18.1%  
Pledged promoter(s) holding % 0.0 14.9 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   SUN PHARMA    CIPLA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    



Today's Market

Sensex Ends 150 Points Lower, Nifty Falls Below 15,800; FMCG & Banking Stocks Witness Selling(Closing)

After opening deep in the red, Indian share markets recovered most of the losses as the session progressed but still ended on a negative note.

Related Views on News

J B Chemicals & Pharma's Decent Performance Puts Stock in Focus (Views On News)

Aug 13, 2021

The company seeks to expand the market for prescription lozenges with new launches this year.

Aurobindo Pharma Rallies on Sale of Injectables Unit to Subsidiary (Views On News)

Jul 2, 2021

Here's why the company sold its business unit to Eugia Pharma Specialities.

5 Takeaways from Sun Pharma's Q4 Results (Views On News)

May 30, 2022

It came as a surprise to everyone when Sun Pharma reported a consolidated net loss in Q4 instead of a profit.

Why Divi's Lab Share Price is Falling (Views On News)

May 24, 2022

Here's why Divi's Lab's stock fell over 10% in two days.

Divi's Lab Net Profit Rises 78%. Company Declares 1,500% Dividend (Views On News)

May 23, 2022

For full year, profit figures stood at Rs 29.6 bn as against Rs 19.8 bn for the previous year, reflecting a growth of 49%.

More Views on News

Most Popular

4 Sectors to Watch for Future Multibagger Stocks(Views On News)

Jun 17, 2022

With India's economic recovery accelerating, these sectors are likely to give multibagger returns in the future.

Best Monopoly Stocks to Own in 2022(Views On News)

Jun 18, 2022

Constant product innovation, latest technology, strong supply chain etc can all help companies enjoy monopoly like fortunes.

Is it Time to Start Buying Stocks Selectively?(Profit Hunter)

Jun 16, 2022

Some sectors have corrected by 50%. Do they merit a look?

The One Smallcap Stock I'll Recommend Now(Profit Hunter)

Jun 21, 2022

This aspect of investing has a very high weightage on your overall returns, but often gets ignored when winning stories are written.

The Greatest Dividend Stock of All Time is...(Views On News)

Jun 16, 2022

Prudent investors should consider dividend aristocrats to create passive, predictable, and growing income to rely on whether the market moves up or down in these uncertain times.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Jun 29, 2022 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS